LIPOPROTEIN-LIPASE - STRUCTURE, FUNCTION AND MECHANISM OF ACTION

被引:39
作者
SANTAMARINAFOJO, S
BREWER, HB
机构
[1] Molecular Disease Branch, National Heart, Lung and Blood Institute, National Institute of Health, Bethesda, 20892, MD, 9000 Rockville Pike
关键词
HYPERTRIGLYCERIDEMIA; CHYLOMICRONEMIA; LIPASE; STRUCTURE-FUNCTION; SITE-DIRECTED MUTAGENESIS;
D O I
10.1007/BF02592444
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Lipoprotein lipase (LPL) plays a central role in the hydrolysis of circulating triglycerides present in chylomicrons, and very low density lipoproteins. The active form of the enzyme is a non-covalent homodimer which contains multiple functional domains required for normal hydrolytic activity including a catalytic domain, as well as sites involved in co-factor, heparin and lipid binding. Recent studies involving site-directed mutagenesis, the elucidation of the three dimensional crystallographic structure of different lipases, as well as analysis of the molecular defects that result in the expression of the familial chylomicronemia syndrome have provided new insights into the structure-function relationship of LPL. As a result, our understanding of structural domains involved in catalysis, heparin, lipid binding, and enzyme-cofactor interaction as well as the mechanism of action of LPL as an acylglycerol hydrolase has been greatly enhanced.
引用
收藏
页码:143 / 147
页数:5
相关论文
共 39 条
[31]   THE FAMILIAL HYPERCHYLOMICRONEMIA SYNDROME - NEW INSIGHTS INTO UNDERLYING GENETIC-DEFECTS [J].
SANTAMARINAFOJO, S ;
BREWER, HB .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1991, 265 (07) :904-908
[32]  
SPRECHER DL, 1992, J LIPID RES, V33, P859
[33]   MOLECULAR STUDIES ON PRIMARY LIPOPROTEIN-LIPASE (LPL) DEFICIENCY - ONE BASE DELETION (G916) IN EXON-5 OF LPL GENE CAUSES NO DETECTABLE LPL PROTEIN DUE TO THE ABSENCE OF LPL MESSENGER-RNA TRANSCRIPT [J].
TAKAGI, A ;
IKEDA, Y ;
TSUTSUMI, Z ;
SHOJI, T ;
YAMAMOTO, A .
JOURNAL OF CLINICAL INVESTIGATION, 1992, 89 (02) :581-591
[34]   TRYPSIN TREATMENT MAY IMPAIR THE INTERFACIAL ACTIVATION ACTION OF LIPOPROTEIN-LIPASE [J].
TASHIRO, J ;
KOBAYASHI, J ;
SHIRAI, K ;
SAITO, Y ;
NAKAMURA, H ;
MORIMOTO, Y ;
YOSHIDA, S .
JOURNAL OF BIOCHEMISTRY, 1992, 111 (04) :509-514
[35]   INTERFACIAL ACTIVATION OF THE LIPASE PROCOLIPASE COMPLEX BY MIXED MICELLES REVEALED BY X-RAY CRYSTALLOGRAPHY [J].
VANTILBEURGH, H ;
EGLOFF, MP ;
MARTINEZ, C ;
RUGANI, N ;
VERGER, R ;
CAMBILLAU, C .
NATURE, 1993, 362 (6423) :814-820
[36]   MUTATIONS IN EXON-3 OF THE LIPOPROTEIN-LIPASE GENE SEGREGATING IN A FAMILY WITH HYPERTRIGLYCERIDEMIA, PANCREATITIS, AND NON-INSULIN-DEPENDENT DIABETES [J].
WILSON, DE ;
HATA, A ;
KWONG, LK ;
LINGAM, A ;
SHUHUA, J ;
RIDINGER, DN ;
YEAGER, C ;
KALTENBORN, KC ;
IVERIUS, PH ;
LALOUEL, JM .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 92 (01) :203-211
[37]   STRUCTURE OF HUMAN PANCREATIC LIPASE [J].
WINKLER, FK ;
DARCY, A ;
HUNZIKER, W .
NATURE, 1990, 343 (6260) :771-774
[38]  
WISSLER RW, 1992, ARCH PATHOL LAB MED, V116, P1281
[39]   DOMAIN EXCHANGE - CHARACTERIZATION OF A CHIMERIC LIPASE OF HEPATIC LIPASE AND LIPOPROTEIN-LIPASE [J].
WONG, H ;
DAVIS, RC ;
NIKAZY, J ;
SEEBART, KE ;
SCHOTZ, MC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (24) :11290-11294